FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Glenmark Life Sciences IPO and Rolex Rings IPO.
Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Rolex Rings IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Glenmark Life Sciences IPO | Rolex Rings IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Bofa Securities India Limited Bob Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Goldman Sachs (India) Securities Private Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited |
Equirus Capital Private Limited Idbi Capital Market Services Limited Jm Financial Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Rolex Rings IPO is up to ₹731.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Rolex Rings IPO is ₹900.00 per share.
Glenmark Life Sciences IPO | Rolex Rings IPO | |
---|---|---|
Face Value | ₹2 per share | ₹10 per share |
Issue Price (Lower) | ₹695.00 per share | ₹880.00 per share |
Issue Price (Upper) | ₹720.00 per share | ₹900.00 per share |
Issue Price (Final) | ₹720.00 per share | ₹900.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 20 shares | 16 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹1,060.00 Cr | up to ₹56.00 Cr |
OFS Issue Size | 63,00,000 shares | 75,00,000 shares |
OFS Issue Size (Amount) | up to ₹453.60 Cr | up to ₹675.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹1,513.60 Cr | up to ₹731.00 Cr |
Glenmark Life Sciences IPO opens on Jul 27, 2021, while Rolex Rings IPO opens on Jul 28, 2021. The closing date of Glenmark Life Sciences IPO and Rolex Rings IPO is Jul 29, 2021, and Jul 30, 2021, respectively.
Glenmark Life Sciences IPO | Rolex Rings IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jul 27, 2021 | Jul 28, 2021 |
Issue Close | Jul 29, 2021 | Jul 30, 2021 |
Basis Of Allotment (Tentative) | Aug 03, 2021 | Aug 04, 2021 |
Initiation of Refunds (Tentative) | Aug 04, 2021 | Aug 05, 2021 |
Credit of Share (Tentative) | Aug 05, 2021 | Aug 06, 2021 |
Listing date (Tentative) | Aug 06, 2021 | Aug 09, 2021 |
Anchor Lockin End date 1 | Sep 02, 2021 | Sep 03, 2021 |
Anchor Lockin End date 2 | Nov 01, 2021 | Nov 02, 2021 |
Glenmark Life Sciences IPO P/E ratio is , as compared to Rolex Rings IPO P/E ratio of .
Glenmark Life Sciences IPO | Rolex Rings IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 58.99% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 82.84% | 57.64% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Rolex Rings IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 16,24,444 shares in Rolex Rings IPO.
Glenmark Life Sciences IPO | Rolex Rings IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 42,42,379 shares | 16,24,444 shares |
NII | 32,32,770 shares | 12,18,334 shares |
RII | 75,43,130 shares | 28,42,778 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,50,18,279 shares | 56,85,556 shares |
Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Rolex Rings IPO subscribed 130.44x.
Glenmark Life Sciences IPO | Rolex Rings IPO | |
---|---|---|
QIB (times) | 36.97x | 143.58x |
NII (times) | 122.54x | 360.11x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 14.63x | 24.49x |
Employee (times) | ||
Other (times) | ||
Total (times) | 44.17x | 130.44x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|